FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208994203> ?p ?o ?g. }

• W3208994203 abstract "Aim: The authors present real-world data on the efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC). Methods: The Turkish Oncology Group Kidney Cancer Consortium (TKCC) database includes patients with mRCC from 13 cancer centers in Turkey. Patients with mRCC treated with nivolumab in the second line and beyond were extracted from the TKCC database. Results: A total of 173 patients were included. The rates of patients treated with nivolumab in the second, third, fourth and fifth lines were 47.4%, 32.4%, 14.5% and 5.7%, respectively. The median overall survival and progression-free survival were 24.2 months and 9.6 months, respectively. Nivolumab was discontinued owing to adverse events in 11 (6.4%) patients. Conclusion: Nivolumab was effective in patients with mRCC and no new safety signal was observed.Lay abstract Nivolumab is an immune checkpoint inhibitor (ICI) that blocks the communication between T cells and cancer cells and instead activates T cells to fight against cancer. Metastatic renal cell carcinoma (mRCC) is one of the most susceptible tumors to ICIs. The Checkmate 025 trial showed the efficacy of nivolumab in patients with previously treated mRCC. In this real-world study, 173 patients with mRCC were treated with nivolumab in the second line and beyond. Nivolumab was effective in the real-world setting without additional safety concerns." @default.
• W3208994203 created "2021-11-08" @default.
• W3208994203 creator A5001724116 @default.
• W3208994203 creator A5013823331 @default.
• W3208994203 creator A5013941417 @default.
• W3208994203 creator A5019461247 @default.
• W3208994203 creator A5023874099 @default.
• W3208994203 creator A5028500628 @default.
• W3208994203 creator A5029566579 @default.
• W3208994203 creator A5033323622 @default.
• W3208994203 creator A5049847384 @default.
• W3208994203 creator A5052112651 @default.
• W3208994203 creator A5056164245 @default.
• W3208994203 creator A5056352422 @default.
• W3208994203 creator A5058897783 @default.
• W3208994203 creator A5059941445 @default.
• W3208994203 creator A5062129196 @default.
• W3208994203 creator A5063630319 @default.
• W3208994203 creator A5064592414 @default.
• W3208994203 creator A5067436525 @default.
• W3208994203 creator A5071613646 @default.
• W3208994203 creator A5083927273 @default.
• W3208994203 creator A5084659231 @default.
• W3208994203 date "2021-11-02" @default.
• W3208994203 modified "2023-10-16" @default.
• W3208994203 title "Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database" @default.
• W3208994203 cites W2019607817 @default.
• W3208994203 cites W2069701490 @default.
• W3208994203 cites W2078359283 @default.
• W3208994203 cites W2103234365 @default.
• W3208994203 cites W2149456801 @default.
• W3208994203 cites W2150738393 @default.
• W3208994203 cites W2222086386 @default.
• W3208994203 cites W2593338436 @default.
• W3208994203 cites W2792937256 @default.
• W3208994203 cites W2809994753 @default.
• W3208994203 cites W2810478122 @default.
• W3208994203 cites W2911812451 @default.
• W3208994203 cites W2943887705 @default.
• W3208994203 cites W2950990372 @default.
• W3208994203 cites W2969277287 @default.
• W3208994203 cites W3011542086 @default.
• W3208994203 cites W3033436222 @default.
• W3208994203 cites W3042347895 @default.
• W3208994203 cites W3093073703 @default.
• W3208994203 cites W3125629250 @default.
• W3208994203 cites W3131063362 @default.
• W3208994203 cites W3134949580 @default.
• W3208994203 cites W3157244212 @default.
• W3208994203 doi "https://doi.org/10.2217/fon-2021-0717" @default.
• W3208994203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34726480" @default.
• W3208994203 hasPublicationYear "2021" @default.
• W3208994203 type Work @default.
• W3208994203 sameAs 3208994203 @default.
• W3208994203 citedByCount "2" @default.
• W3208994203 countsByYear W32089942032021 @default.
• W3208994203 countsByYear W32089942032022 @default.
• W3208994203 crossrefType "journal-article" @default.
• W3208994203 hasAuthorship W3208994203A5001724116 @default.
• W3208994203 hasAuthorship W3208994203A5013823331 @default.
• W3208994203 hasAuthorship W3208994203A5013941417 @default.
• W3208994203 hasAuthorship W3208994203A5019461247 @default.
• W3208994203 hasAuthorship W3208994203A5023874099 @default.
• W3208994203 hasAuthorship W3208994203A5028500628 @default.
• W3208994203 hasAuthorship W3208994203A5029566579 @default.
• W3208994203 hasAuthorship W3208994203A5033323622 @default.
• W3208994203 hasAuthorship W3208994203A5049847384 @default.
• W3208994203 hasAuthorship W3208994203A5052112651 @default.
• W3208994203 hasAuthorship W3208994203A5056164245 @default.
• W3208994203 hasAuthorship W3208994203A5056352422 @default.
• W3208994203 hasAuthorship W3208994203A5058897783 @default.
• W3208994203 hasAuthorship W3208994203A5059941445 @default.
• W3208994203 hasAuthorship W3208994203A5062129196 @default.
• W3208994203 hasAuthorship W3208994203A5063630319 @default.
• W3208994203 hasAuthorship W3208994203A5064592414 @default.
• W3208994203 hasAuthorship W3208994203A5067436525 @default.
• W3208994203 hasAuthorship W3208994203A5071613646 @default.
• W3208994203 hasAuthorship W3208994203A5083927273 @default.
• W3208994203 hasAuthorship W3208994203A5084659231 @default.
• W3208994203 hasConcept C121608353 @default.
• W3208994203 hasConcept C126322002 @default.
• W3208994203 hasConcept C143998085 @default.
• W3208994203 hasConcept C197934379 @default.
• W3208994203 hasConcept C2777472916 @default.
• W3208994203 hasConcept C2777658100 @default.
• W3208994203 hasConcept C2777701055 @default.
• W3208994203 hasConcept C2780030458 @default.
• W3208994203 hasConcept C2781068499 @default.
• W3208994203 hasConcept C502942594 @default.
• W3208994203 hasConcept C71924100 @default.
• W3208994203 hasConceptScore W3208994203C121608353 @default.
• W3208994203 hasConceptScore W3208994203C126322002 @default.
• W3208994203 hasConceptScore W3208994203C143998085 @default.
• W3208994203 hasConceptScore W3208994203C197934379 @default.
• W3208994203 hasConceptScore W3208994203C2777472916 @default.
• W3208994203 hasConceptScore W3208994203C2777658100 @default.
• W3208994203 hasConceptScore W3208994203C2777701055 @default.
• W3208994203 hasConceptScore W3208994203C2780030458 @default.
• W3208994203 hasConceptScore W3208994203C2781068499 @default.
• W3208994203 hasConceptScore W3208994203C502942594 @default.

• next